MediPurpose of Norcross, Georgia has released the babyLance, a new infant heel lancing device for taking blood test samples, usually done just after birth for blood glucose measurement, etc. The product comes in two lance depth sizes, 0.85 mm for preemies and 1.00 mm for newborns.
Features from the press release:
Ease of activation: Reduces trigger activation force, thereby significantly reducing the risk of bruising. Unique positioning design: Facilitates a stable and accurate placement against the targeted section of the infant’s heel while ensuring the procedure can be performed consistently and quickly. Compliance with regulatory and quality standards: Manufactured to the same regulatory and quality standards as the SurgiLance® safety lancet, the babyLance™ cutting blade’s swift pendulum action makes an incision that complies with the CLSI LA4-A5 established guidelines. Cost effectiveness: The babyLance™ heel incision device incorporates unique design characteristics that allow for the most cost-effective manufacturing process.
Press release: MediPurpose Launches New babyLance Infant Heel Incision Device…
Product page: babyLance…